Stephen R. Petteway

5.6k total citations · 1 hit paper
47 papers, 4.8k citations indexed

About

Stephen R. Petteway is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Stephen R. Petteway has authored 47 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 19 papers in Molecular Biology and 15 papers in Infectious Diseases. Recurrent topics in Stephen R. Petteway's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (12 papers) and Prion Diseases and Protein Misfolding (9 papers). Stephen R. Petteway is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (12 papers) and Prion Diseases and Protein Misfolding (9 papers). Stephen R. Petteway collaborates with scholars based in United States, Switzerland and Austria. Stephen R. Petteway's co-authors include Flossie Wong‐Staal, Lucinda A. Ivanoff, Robert C. Gallo, Lee Ratner, John Ghrayeb, Kenneth J. Livak, Erik A. Whitehorn, B Starcich, William A. Haseltine and Steven F. Josephs and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Stephen R. Petteway

47 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete nucleotide sequence of the AIDS virus, HTLV-III

1985 2.0k citations Lucinda A. Ivanoff, Stephen R. Petteway et al. profile →

Peers

Stephen R. Petteway

VIROL

IMMUN

EPIDE

W A Haseltine United States

Marc Alizon France

Denise Guétard France

Tatyana Dorfman United States

R L Willey United States

Andrew I. Dayton United States

Peter L. Nara United States

Wei Chun Goh United States

Robin A. Weiss United Kingdom

Tatsuo Shioda Japan

W A Haseltine United States

Stephen R. Petteway

2.8k ×0.9

VIROL

1.6k ×0.8

1.3k ×0.8

1.5k ×1.1

IMMUN

906 ×0.9

EPIDE

Citations per year, relative to Stephen R. Petteway Stephen R. Petteway (= 1×) peers W A Haseltine

Countries citing papers authored by Stephen R. Petteway

Since Specialization

Citations

This map shows the geographic impact of Stephen R. Petteway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R. Petteway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R. Petteway more than expected).

Fields of papers citing papers by Stephen R. Petteway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen R. Petteway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R. Petteway. The network helps show where Stephen R. Petteway may publish in the future.

Co-authorship network of co-authors of Stephen R. Petteway

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen R. Petteway. A scholar is included among the top collaborators of Stephen R. Petteway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen R. Petteway. Stephen R. Petteway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crumrine, R. Christian, Victor J. Marder, Guillaume Taylor, et al.. (2011). Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model. PubMed. 3(1). 10–10. 17 indexed citations

Goyal, Abha, Guillermo Moreno, Jennifer A. Hunt, et al.. (2010). Haemostatic safety of a unique recombinant plasmin molecule lacking kringles 2–5. Thrombosis and Haemostasis. 104(10). 780–787. 5 indexed citations

Bauman, Patricia, L. Biesert, H. Dichtelmüller, et al.. (2006). Critical factors influencing prion inactivation by sodium hydroxide. Vox Sanguinis. 91(1). 34–40. 18 indexed citations

Burdick, Michael D., Dominique Pifat, Stephen R. Petteway, & Kang Cai. (2005). Clearance of Prions During Plasma Protein Manufacture. Transfusion Medicine Reviews. 20(1). 57–62. 15 indexed citations

Nelson, Mark, Christopher J. Stenland, Jeanette L. C. Miller, et al.. (2005). An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins. Journal of Virological Methods. 125(2). 187–193. 10 indexed citations

Trejo, Stephen J., et al.. (2003). Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. Vox Sanguinis. 84(3). 176–187. 51 indexed citations

Petteway, Stephen R., et al.. (2002). Pathogen safety of manufacturing processes for biological products: special emphasis on KOGENATE^® Bayer. Haemophilia. 8(s2). 6–9. 11 indexed citations

Miller, Jeanette L. C., Stephen R. Petteway, & Douglas C. Lee. (2001). Ensuring the pathogen safety of intravenous immunoglobulin and other human plasma–derived therapeutic proteins☆☆☆. Journal of Allergy and Clinical Immunology. 108(4). S91–S94. 16 indexed citations

Lee, Douglas C., Christopher J. Stenland, Jeanette L. C. Miller, et al.. (2001). A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion. 41(4). 449–455. 78 indexed citations

10.

Matthews, Thomas J., et al.. (1996). Potent Inhibition of HIV Type 1 Infection of Mononuclear Phagocytes by Synthetic Peptide Analogs of HIV Type 1 Protease Substrates. AIDS Research and Human Retroviruses. 12(9). 777–782. 2 indexed citations

11.

Black, Paul L., Michael A. Ussery, Shawn Barney, et al.. (1996). Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice. Antiviral Research. 29(2-3). 175–186. 3 indexed citations

12.

Bhatnagar, Pradip K., et al.. (1994). Efficacy of the hematoregulatory peptide SK&F 107647 in experimental systematic Candida albicans infections in normal and immunosuppressed mice. Immunopharmacology. 27(3). 199–206. 14 indexed citations

13.

Ivanoff, Lucinda A., J W Dubay, Susan Jo Roberts, et al.. (1992). V3 Loop region of the HIV-1 gpl20 envelope protein is essential for virus infectivity. Virology. 187(2). 423–432. 85 indexed citations

14.

Ivanoff, Lucinda A., David J. Looney, Charlene McDanal, et al.. (1991). Alteration of HIV-1 Infectivity and Neutralization by a Single Amino Acid Replacement in the V3 Loop Domain. AIDS Research and Human Retroviruses. 7(7). 595–603. 82 indexed citations

15.

Petteway, Stephen R., Dennis M. Lambert, & Brian W. Metcalf. (1991). The chronically infected cell as a target for the treatment of HIV infection and AIDS. Trends in Pharmacological Sciences. 12(1). 28–34. 11 indexed citations

16.

Veronese, Fulvia, Rukhsana Rahman, Vaniambadi S. Kalyanaraman, et al.. (1989). Monoclonal Antibodies to HTLV-III ₄₅₁ gp41: Delineation of an Immunoreactive Conserved Epitope in the Transmembrane Region of Divergent Isolates of HIV-1. AIDS Research and Human Retroviruses. 5(5). 479–486. 4 indexed citations

17.

Kenealy, William R., et al.. (1989). Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in Animals. AIDS Research and Human Retroviruses. 5(2). 173–182. 56 indexed citations

18.

Rinaldo, Charles R., Paolo Piazza, John A. Armstrong, et al.. (1988). HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection.. The Journal of Immunology. 140(10). 3389–3393. 24 indexed citations

19.

Lyerly, H. Kim, et al.. (1987). Anti-GP 120 Antibodies from HIV Seropositive Individuals Mediate Broadly Reactive Anti-HIV ADCC. AIDS Research and Human Retroviruses. 3(4). 409–422. 111 indexed citations

20.

Kenealy, William R., D. E. Tribe, P. E. Taylor, et al.. (1987). Analysis of Human Serum Antibodies to Human Immunodeficiency Virus (HIV) Using Recombinant ENV and GAG Antigens. AIDS Research and Human Retroviruses. 3(1). 95–105. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact